Related Experiment Videos
Physician attitudes and prescribing practices: a focus on minor tranquilizers
Journal of Psychoactive Drugs
|January 1, 1983
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Trajectories of prenatal alcohol exposure and behavioral outcomes: Findings from a community-based sample.
Drug and alcohol dependence·2022
The impact of micronutrient supplementation in alcohol-exposed pregnancies on reaction time responses of preschoolers in Ukraine.
Alcohol (Fayetteville, N.Y.)·2021
Implications of altered maternal cytokine concentrations on infant outcomes in children with prenatal alcohol exposure.
Alcohol (Fayetteville, N.Y.)·2018
Autoimmune conditions and comorbid depression in pregnancy: examining the risk of preterm birth and preeclampsia.
Journal of perinatology : official journal of the California Perinatal Association·2017
Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary.
Clinical pharmacology and therapeutics·2017
Psychedelic Use Covaries with Psychological Flexibility Through Mystical Experiences: Results of a Retrospective Web Survey.
Journal of psychoactive drugs·2026
Empathy and Love as Protective Factors in Opioid Use Disorder Recovery.
Journal of psychoactive drugs·2026
The Perceived Value of Risk Reduction Programs in High-Risk Areas in Malaysia.
Journal of psychoactive drugs·2026
Mystical Experiences as Catalysts in Ketamine-Assisted Psychotherapy: A Case Study.
Journal of psychoactive drugs·2026
Natural Product Echinocandin Derivative S4286 Induces Mitochondrial Dysfunction to Combat Sclerotinia sclerotiorum.
Journal of agricultural and food chemistry·2026
From SHP2 to DDR1-ERK: A critical signaling axis controlling microglial activation and neuropathic pain after spinal cord injury.
General physiology and biophysics·2026
Association of Cannabis Use With Risk of Subsequent Falls Among Adults Aging With HIV.
Open forum infectious diseases·2026
Bestatin inhibits the development of cutaneous melanoma by inhibiting the expression of LTA4H.
Frontiers in immunology·2026